Scientists have tested a patch against skin cancer

Scientists have developed an experimental skin patchwhich in animal experiments was able to reduce tumors melanoma on 97% in just 10 days.

The method is based on local release copper ions after activating the patch with a weak laser. The results look promising, but so far we are talking only about preclinical trials on mice, and not about a ready-made treatment for people.

The study was published in the journal ACS Nanoand its main conclusions are given American Chemical Society. This is a stretchable and transparent patch that is applied to the area of ​​skin above the tumor and activated by a low-energy laser.

After heating to approximately 42°C the patch begins to release copper ions directly to the tumor area. These ions trigger oxidative stress and cell death mechanisms in cancer cells, including apoptosis, cuproptosis, and ferroptosis. It sounds like a set of spells from a biochemistry textbook, but the meaning is simple: tumor cells are hit directly in the affected area, and the surrounding tissues, according to the experiment, remain relatively protected.

What the experiments showed

In laboratory conditions, copper ions destroyed most of the cultured cells melanoma and slowed down their movement. The patch was then tested on mice with melanoma tumors. For 10 days The animals underwent two hour-long laser activation sessions – on the first and fifth day.

According to the study, this scheme led to a decrease in tumor lesions by 97%. Tissue analysis also showed that cancer cells had not spread beyond the tumor, and copper ions did not accumulate in the blood and internal organs. This is also reported EurekAlert.

? A CANCER PATCH THAT SOUNDS IMPOSSIBLE

Scientists have developed a wearable skin patch that reduced melanoma tumors in mice by an incredible 97% in just 10 days.
The patch is activated by a low-power laser, releasing copper ions directly into the tumor area while leaving… pic.twitter.com/OR6RXWg5Y9

—Next Science (@NextScience) June 4, 2026

For oncology, this is an important detail: the potential value of the method is not only in the destruction of the tumor, but also in the locality of the effect. The more accurately a therapy hits cancer cells and the less it affects healthy tissue, the higher its chances of becoming useful in the clinic. True, between the mouse and the patient lies a long road of clinical trials, and medicine, fortunately, is not obliged to believe every beautiful graph at first glance.

Why is this important

Melanoma – one of the most aggressive types of skin cancer. It is often treated with surgical removal, and in more complex cases, immunotherapy, targeted therapy, radiation or combination treatments are used. Therefore, a non-invasive method that could affect the tumor locally, without surgery and serious damage to surrounding tissue, is of great interest.

The developed patch could potentially become the basis for less traumatic approaches to the treatment of superficial skin tumors. But for now that’s it potentially. Researchers still need to test the safety, dosage, penetration depth, effectiveness on different types of tumors and the behavior of the technology in the human body.

The main limitation: people have not yet been treated

The most important point, which should not be hidden in the fine print at the end: the patch has not yet been tested in humans. All data on tumor reduction by 97% obtained in a mouse model melanoma. This is a serious result for the laboratory, but does not guarantee that the same effect will be repeated in patients.

Many oncology treatments work successfully in animals but then fail in clinical trials due to toxicity, lack of efficacy, or technical limitations. Therefore talk about “revolutionary cancer treatment” It’s too early. Talking about promising technology – yes. Promising people a cure – no, let’s leave that to the charlatans, they already have a busy schedule.

If further studies confirm the safety and effectiveness of the method, the controlled-release copper ion patch could become part of a new generation of local antitumor therapies. But it still has to go through clinical trials before hospitals and real patients.

Editorial comment

The story of the patch against melanoma is a good example of how to read medical news. On the one hand, the result is really impressive: 97% tumor reduction in mice 10 days – this is not a small thing. On the other hand, it is not yet a cure, a procedure for patients, or a replacement for existing cancer care.

Science moves this way: first the laboratory, then animals, then long and expensive tests on humans. Therefore, you can rejoice, but without hysteria. A new patch could prove an important step in the treatment of skin cancer. Or it may remain one of hundreds of promising technologies that looked great in mice and never made it to the clinic. In medicine, hope is needed, but verification is needed even more.

Source link